Endoglin as a target of antitumor therapy

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Blood vascular supply significantly affects progression of tumor growth. Inhibition of endothelial cell proliferation by antiangiogenic drugs should lead to growth arrest of both primary tumors and metastases. During the course of lengthy therapy, endothelial cells may, however, become refractory to the action of antiangiogenic agents. Novel approaches to anticancer treatment should explore the issue of drug resistance shown by endothelial cells. One possible therapeutic solution might be tumor immunotherapy directed against antigens expressed on the surface of endothelial cells which co-form tumor blood vasculature. Such therapy is supposed to break immune tolerance to own antigens and to eliminate tumor blood vessel endothelial cells by activating cytotoxic T lymphocytes. This kind of response can be obtained against endoglin (CD105). Endoglin is overexpressed in proliferating endothelial cells which line tumor blood vessels. Presence of endoglin in solid tumor blood vessels has prognostic value in cancer treatment. CD105 is also expressed by certain cancer cells (prostate, melanoma and Ewing sarcoma). It appears that therapeutic strategies directed against endoglin allow several mechanisms of resistance to antiangiogenic drugs to be omitted. The therapeutic approach that we propose, i.e. a tumor blood vessel-destroying strategy combined with immunotherapy, may become an effective therapeutic tool.

Authors and Affiliations

Magdalena Jarosz, Stanisław Szala

Keywords

Related Articles

Mechanisms of osteoporosis development in patients with rheumatoid arthritis

Rheumatoid arthritis (RA) is progressive, chronic, autoimmune, systemic connective tissue disease. It affects 0,5-1% population. RA manifests as inflammation of symmetrical mainly small and medium joints with synovial hy...

PARP inhibitors – theoretical basis and clinical application

Poly-ADP-ribose polymerases (PARP) are involved in a number of processes that are vital for every living cell. Once activated by the presence of DNA damage they trigger poly-ADP-ribosylation of various proteins which ar...

Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro

Cytochrome P450 proteins are the most important enzymes involved in metabolic activation or detoxification of various drugs used in clinical practice. However, some drug metabolism pathways may be responsible for their...

Właściwości odżywcze i alergizujące jaj kurzych

Jaja kurze charakteryzują się cennymi wartościami odżywczymi i są drugim po mleku krowim, pokarmem obcogatunkowym wprowadzanym do diety dziecka. Pewne składniki jaja wykazują również inne niż dietetyczne właściwości biol...

Perspective in optimization of stem cell therapies for heart regeneration

There is a variety of mechanisms(s) factor(s) that may influence stem cell therapies for heart regeneration. Among the best candidates for stem cell source are: mesenchymal stem cells (also those isolated from adipose ti...

Download PDF file
  • EP ID EP66861
  • DOI -
  • Views 141
  • Downloads 0

How To Cite

Magdalena Jarosz, Stanisław Szala (2013). Endoglin as a target of antitumor therapy . Advances in Hygiene and Experimental Medicine, 67(0), 79-89. https://europub.co.uk/articles/-A-66861